| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| N797890 | MACKLIN | 盐酸尼卡地平 | 10mM in DMSO | 185元/1ml; | 展开 |
|
| N838247 | MACKLIN | 盐酸尼卡地平 | 98% | 75元/100mg; 222元/1g; 573元/5g; 1952元/25g; | 展开 |
|
| N0635 | TCI | Nicardipine Hydrochloride | >98.0%(T)(HPLC) | 590元/5G; 1690元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C26H29N3O6·HCl = 515.99 | | 外观与形状(20℃) | 固体 | | 应避免的情况 | 光 | | 相关CAS RN | 55985-32-5 | | Reaxys-RN | 4286471 | | PubChem物质ID | 87573949 | | Merck Index (14) | 6495 | | MDL编号 | MFCD00057327 |
技术规格 | Appearance | White to Light yellow to Green powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in Methanol | almost transparency |
安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P301 + P310 + P330 : 如误吞咽：立即呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| N7510 | Sigma-Aldrich | Nicardipine Hydrochloride | powder, ≥98% | 1561.97元/1 G; 4996.28元/5 G; 7494.43元/10 G; | 展开 |
产品说明 生化/生理作用 阻断 L 型电压依赖性钙通道；抗高血压药。 特点和优势 该化合物由 EKR Therapeutics 开发 。要浏览其他制药公司开发的化合物列表批准的药物/候选药物的列表， 点击这里 。 基本信息 | 经验(实验)分子式 | C26H29N3O6 · HCl | | 分子量 | 515.99 | | EC 号 | 259-198-4 | | MDL编号 | MFCD00057327 | | PubChem化学物质编号 | 24277856 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 测定 | ≥98% | | 形式 | powder | | 颜色 | yellow | | 溶解性 | DMSO: ~1 mg/mL
0.1 M NaOH: insoluble
H2O: slightly soluble
methanol: soluble | | 创始人 | EKR Therapeutics | | 储存温度 | 2-8℃ | | SMILES string | Cl[H].COC(=O)C1=C(C)NC(C)=C(C1c2cccc(c2)[N+]([O-])=O)C(=O)OCCN(C)Cc3ccccc3 | | InChI | 1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H | | InChI key | AIKVCUNQWYTVTO-UHFFFAOYSA-N | | Gene Information | human ... CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 + H311 + H331 | | 预防措施声明 | P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 | | 危险分类 | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| Y0001917 | | Nicardipine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1697.05元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C26H29N3O6 · HCl | | 分子量 | 515.99 | | EC 号 | 259-198-4 | | MDL编号 | MFCD00057327 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl[H].COC(=O)C1=C(C)NC(C)=C(C1c2cccc(c2)[N+]([O-])=O)C(=O)OCCN(C)Cc3ccccc3 | | InChI | 1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H | | InChI key | AIKVCUNQWYTVTO-UHFFFAOYSA-N | | Gene Information | human ... CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 + H311 + H331 | | 预防措施声明 | P261 - P280 - P301 + P330 + P331 + P310 - P302 + P352 + P312 - P304 + P340 + P311 - P403 + P233 | | 危险分类 | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001924 | | Nicardipine Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1250.01元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C26H29N3O6 · HCl | | 分子量 | 515.99 | | MDL编号 | MFCD00057327 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl[H].COC(=O)C1=C(C)NC(C)=C(C1c2cccc(c2)[N+]([O-])=O)C(=O)OCCN(C)Cc3ccccc3 | | InChI | 1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H | | InChI key | AIKVCUNQWYTVTO-UHFFFAOYSA-N | | Gene Information | human ... CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 + H311 + H331 | | 预防措施声明 | P261 - P280 - P301 + P330 + P331 + P310 - P302 + P352 + P312 - P304 + P340 + P311 - P403 + P233 | | 危险分类 | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR2531 | Supelco | Nicardipine Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material | 3065.6元/500 MG; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC5257 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C26H29N3O6 · HCl | | 分子量 | 515.99 | | MDL编号 | MFCD00057327 |
产品性质 | 等级 | certified reference material
pharmaceutical secondary standard | | 形式 | powder | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | 药典可追溯性 | traceable to PhEur Y0001924
traceable to USP 1463224 | | 储存温度 | 2-30℃ | | SMILES string | Cl[H].COC(=O)C1=C(C)NC(C)=C(C1c2cccc(c2)[N+]([O-])=O)C(=O)OCCN(C)Cc3ccccc3 | | InChI | 1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H | | InChI key | AIKVCUNQWYTVTO-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 + H311 + H331 | | 预防措施声明 | P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 | | 危险分类 | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1463224 | USP | Nicardipine Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C26H29N3O6 · HCl | | 分子量 | 515.99 | | MDL编号 | MFCD00057327 | | PubChem化学物质编号 | 329750555 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl[H].COC(=O)C1=C(C)NC(C)=C(C1c2cccc(c2)[N+]([O-])=O)C(=O)OCCN(C)Cc3ccccc3 | | InChI | 1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H | | InChI key | AIKVCUNQWYTVTO-UHFFFAOYSA-N | | Gene Information | human ... CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 + H311 + H331 | | 预防措施声明 | P261 - P280 - P301 + P330 + P331 + P310 - P302 + P352 + P312 - P304 + P340 + P311 - P403 + P233 | | 危险分类 | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 358133 | Fluorochem | 3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride | >98.0%(HPLC)(T) | 2596元/5g; 5940元/25g; | 展开 |
基本信息 | CAS Number | 54527-84-3 | | MDL Number | MFCD00057327 |
|
m.cnreagent.com